Profarma Distribuidora de Produtos Farmacêuticos S.A.

São Paulo Stock Exchange PFRM3.SA

Profarma Distribuidora de Produtos Farmacêuticos S.A. Gross Profit Margin for the year ending December 31, 2023: 14.92%

Profarma Distribuidora de Produtos Farmacêuticos S.A. Gross Profit Margin is 14.92% for the year ending December 31, 2023, a 1.78% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. Gross Profit Margin for the year ending December 31, 2022 was 14.66%, a 3.56% change year over year.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. Gross Profit Margin for the year ending December 31, 2021 was 14.15%, a 1.59% change year over year.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. Gross Profit Margin for the year ending December 31, 2020 was 13.93%, a -9.35% change year over year.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. Gross Profit Margin for the year ending December 31, 2019 was 15.37%, a -3.60% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
São Paulo Stock Exchange: PFRM3.SA

Profarma Distribuidora de Produtos Farmacêuticos S.A.

CEO Mr. Sammy Birmarcker
IPO Date Oct. 26, 2006
Location Brazil
Headquarters Avenida Ayrton Senna 2.150
Employees 7,077
Sector Health Care
Industries
Description

Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Distribution, and Retail segments. It provides branded medicines, generic drugs, and over-the-counter (OTC) medicines; personal hygiene, beauty, and cosmetic products, such as shampoos, conditioners, treatment creams and hair dyes, diapers and children's products, soaps , deodorants, oral care products, sunscreens, male products, cosmetics, makeup and skin products, and others; and hospital products, including injectable and infusion drugs for oncology, endocrinology, rheumatology, infectology, hematology, and other specialties. The company also offers vaccines for influenza, HPV, meningitis, hepatitis, chickenpox, dengue, and other diseases; special medicines intended for the treatment of rare and complex diseases; exclusive hygiene and beauty products, vitamins, and workshops products under the Nº21, GOnutri, and Bem Básico brands; and convenience products, including food products, pressure gauges, scales, and related products. In addition, it provides complementary services, such as promotional and logistical support, implementation of promotional campaigns, product recall, development of customized projects to offer laboratories solutions, and management of clinical procedures. As of December 31, 2019, the company operated eleven distribution centers located in the states of Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo, as well as approximately 196 stores in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário brands. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil.

Similar companies

TCSA3.SA

Tecnisa S.A.

USD 0.23

-0.87%

POSI3.SA

Positivo Tecnologia S.A.

USD 0.82

-0.45%

JHSF3.SA

JHSF Participações S.A.

USD 0.61

1.93%

ODPV3.SA

Odontoprev S.A.

USD 1.77

2.65%

StockViz Staff

January 15, 2025

Any question? Send us an email